COLORADO SPRINGS, Colo., June 15, 2010 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTCBB:CBIS), a pioneering U.S. biotech company developing pharmaceutical cannabis products announces Federal Court order for CBIS shares owned by Cannex Therapeutics controlled by Steve Kubby to be cancelled and re-issued to K&D. Both K&D and Cannabis Science denounce the “slanderous, malicious attacks” on the Company by its fired CEO Steve Kubby. Both parties are assessing additional legal action against Steve Kubby for his continued attacks against Cannabis Science, its shareholders, and the company’s current management team as a safeguard to defend shareholder interest.